129Xe MRI Cardiopulmonary
NCT06038630
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Interstitial Lung Disease
- Chronic Thromboembolic Pulmonary Hypertension
- Acute Pulmonary Embolism
- Anemia
- Polycythemia
- Dyspnea
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Bastiaan Driehuys
- Last updated on ClinicalTrials.gov
- February 4, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
North Carolina · 1
- Duke University Medical Center · Durham, NC
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.